| scholarly article | Q13442814 |
| P2093 | author name string | Privitera G | |
| de Lalla F | |||
| Ortisi G | |||
| Nicastro G | |||
| Scarpellini P | |||
| Nicolin R | |||
| P2860 | cites work | Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis | Q34281870 |
| Diarrhoea due to Clostridium difficile associated with antibiotic treatment in patients receiving dialysis: the role of cross infection | Q34283077 | ||
| Clostridium difficile and its cytotoxin in infants admitted to hospital with infectious gastroenteritis. | Q34556396 | ||
| Treatment of Clostridium difficile-associated disease with teicoplanin | Q35566657 | ||
| Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. | Q36493837 | ||
| Isolation of Clostridium difficile from patients and the environment of hospital wards | Q39504064 | ||
| Selective enrichment broth culture for detection of Clostridium difficile and associated cytotoxin. | Q40218709 | ||
| Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. | Q40224029 | ||
| Pseudomembranous colitis. A fatal case following prophylactic cephaloridine therapy | Q41693404 | ||
| Nosocomial acquisition of Clostridium difficile infection | Q41877583 | ||
| Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment | Q43325209 | ||
| Epidemiological aspects of Clostridium difficile-induced diarrhea and colitis | Q43462617 | ||
| Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital. | Q50535785 | ||
| Diagnosis and epidemiology of Clostridium difficile enterocolitis in Sweden. | Q54464020 | ||
| Effect of Broad-Spectrum Cephalosporins on the Microbial Flora of Recipients | Q54489049 | ||
| Pseudomembranous colitis following prophylactic antibiotic use in primary cesarean section | Q61840076 | ||
| Changing epidemiology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis | Q69541367 | ||
| A role for colonic stasis in the pathogenesis of disease related to Clostridium difficile | Q69689718 | ||
| Is Clostridium difficile endemic in chronic-care facilities? | Q69883413 | ||
| Evaluation of mezlocillin in elective gastrointestinal surgery | Q70282603 | ||
| Nosocomial spread of Clostridium difficile | Q70821860 | ||
| Clinical and laboratory observations in Clostridium difficile colitis | Q71386018 | ||
| Toxigenicity of Clostridium difficile isolates from patients and healthy adults | Q71487873 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Clostridium difficile | Q310543 |
| P304 | page(s) | 208-210 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery | |
| P478 | volume | 35 |
| Q63230054 | 2019 update of the WSES guidelines for management of () infection in surgical patients |
| Q37039028 | Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery. |
| Q44945542 | Antibiotic prescribing policy and Clostridium difficile diarrhoea |
| Q24234378 | Antibiotic treatment for Clostridium difficile -associated diarrhea in adults |
| Q30235446 | Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults |
| Q37412959 | Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem |
| Q28083860 | Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications |
| Q56225357 | Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) |
| Q33375824 | Clinical review of the management of fulminant clostridium difficile infection |
| Q36211666 | Clostridium difficile MazF toxin exhibits selective, not global, mRNA cleavage |
| Q37465285 | Clostridium difficile colonization and antibiotics response in PolyFermS continuous model mimicking elderly intestinal fermentation. |
| Q44549564 | Clostridium difficile infection: a surgical disease in evolution |
| Q36081367 | Clostridium difficile: an update |
| Q38334278 | Diagnosis and treatment of Clostridium difficile in adults: a systematic review. |
| Q41564213 | Drug-induced Clostridium difficile-associated disease |
| Q36396259 | Effects of an Educational Module in Rationalizing Surgical Prophylaxis |
| Q35134579 | Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis |
| Q35789964 | Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study |
| Q36758471 | Influence of ceftriaxone on emergence of Clostridium difficile |
| Q34590126 | Introduction: Antibiotic prophylaxis in clean surgery |
| Q41324828 | Nosocomial infections and nosocomial pneumonia |
| Q38032858 | Novel management strategies in the treatment of severe Clostridium difficile infection. |
| Q94400306 | Perioperative antibiotics for preventing post‐surgical site infections in solid organ transplant recipients |
| Q71570466 | Prospective evaluation of antibiotic prophylaxis prior to cystometrogram and/or cystogram studies: oral versus intramuscular routes |
| Q34756288 | Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam |
| Q34475773 | Risk factors for Clostridium difficile infection |
| Q34450149 | Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital |
| Q38214577 | Surgical Management of Severe Colitis in the Intensive Care Unit |
| Q62686173 | Systematic review of the cost-effectiveness of preoperative antibiotic prophylaxis in reducing surgical-site infection |
| Q37099977 | Systemic antibiotic prophylaxis not needed for microsurgical varicocelectomy |
| Q37421057 | The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s |
| Q40641598 | The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients |
| Q37866629 | Treatment of refractory and recurrent Clostridium difficile infection |
| Q26795429 | WSES guidelines for management of Clostridium difficile infection in surgical patients |
| Q51211998 | [Impact of antibiotic prophylaxis on microbial ecology] |
| Q72307107 | [Microbiologic criteria of the choice of antibiotic for antibiotic prophylaxis in surgery] |
| Q56559610 | colitis and zoonotic origins-a narrative review |
Search more.